Let’s collaborate differently

Part of doing things differently means getting your feedback. What we’re doing right. What could be improved. What you’d like to see in the future. All of it is important to us. So, feel free to reach out.

Sign up for news, events, updates, and more—as new resources become
available, we'll deliver them right to your inbox to keep you informed.

All fields required.
US resident?

Many gene therapies for hemophilia are being studied in people to determine if they are safe and effective. No gene therapies for hemophilia have been approved for use.

This site and the contents within were created for educational purposes only. The content is not prescriptive and should not replace consultation with a trained healthcare provider. Information regarding gene therapy is provided as a general overview and is not comprehensive.

Many gene therapies for hemophilia are being studied in people to determine if they are safe and effective. No gene therapies for hemophilia have been approved for use.

This site and the contents within were created for educational purposes only. The content is not prescriptive and should not replace consultation with a trained healthcare provider. Information regarding gene therapy is provided as a general overview and is not comprehensive.

  • Responsive image
  • © 2018 BioMarin. All rights reserved. MMRC-GTH-0040 05/19

  • This site is an educational service brought to you by BioMarin Hemophilia and is intended for US residents only.
    No gene therapies for hemophilia A or B have been approved for use or determined to be safe or effective.

  • © 2018 BioMarin. All rights reserved.
    MMRC-GTH-0040 05/19